Characterization studies of human tissue-type plasminogen activator produced by recombinant DNA technology. 1986

G A Vehar, and M W Spellman, and B A Keyt, and C K Ferguson, and R G Keck, and R C Chloupek, and R Harris, and W F Bennett, and S E Builder, and W S Hancock

UI MeSH Term Description Entries
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D010449 Peptide Mapping Analysis of PEPTIDES that are generated from the digestion or fragmentation of a protein or mixture of PROTEINS, by ELECTROPHORESIS; CHROMATOGRAPHY; or MASS SPECTROMETRY. The resulting peptide fingerprints are analyzed for a variety of purposes including the identification of the proteins in a sample, GENETIC POLYMORPHISMS, patterns of gene expression, and patterns diagnostic for diseases. Fingerprints, Peptide,Peptide Fingerprinting,Protein Fingerprinting,Fingerprints, Protein,Fingerprint, Peptide,Fingerprint, Protein,Fingerprinting, Peptide,Fingerprinting, Protein,Mapping, Peptide,Peptide Fingerprint,Peptide Fingerprints,Protein Fingerprint,Protein Fingerprints
D010959 Tissue Plasminogen Activator A proteolytic enzyme in the serine protease family found in many tissues which converts PLASMINOGEN to FIBRINOLYSIN. It has fibrin-binding activity and is immunologically different from UROKINASE-TYPE PLASMINOGEN ACTIVATOR. The primary sequence, composed of 527 amino acids, is identical in both the naturally occurring and synthetic proteases. Alteplase,Plasminogen Activator, Tissue-Type,T-Plasminogen Activator,Tissue-Type Plasminogen Activator,Actilyse,Activase,Lysatec rt-PA,TTPA,Tisokinase,Tissue Activator D-44,Lysatec rt PA,Lysatec rtPA,Plasminogen Activator, Tissue,Plasminogen Activator, Tissue Type,T Plasminogen Activator,Tissue Activator D 44,Tissue Type Plasminogen Activator
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D004274 DNA, Recombinant Biologically active DNA which has been formed by the in vitro joining of segments of DNA from different sources. It includes the recombination joint or edge of a heteroduplex region where two recombining DNA molecules are connected. Genes, Spliced,Recombinant DNA,Spliced Gene,Recombinant DNA Research,Recombination Joint,DNA Research, Recombinant,Gene, Spliced,Joint, Recombination,Research, Recombinant DNA,Spliced Genes
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D005341 Fibrinolysin A product of the lysis of plasminogen (profibrinolysin) by PLASMINOGEN activators. It is composed of two polypeptide chains, light (B) and heavy (A), with a molecular weight of 75,000. It is the major proteolytic enzyme involved in blood clot retraction or the lysis of fibrin and quickly inactivated by antiplasmins. Plasmin,Fibrogammin,Glu-Plasmin,Protease F,Thrombolysin,Glu Plasmin

Related Publications

G A Vehar, and M W Spellman, and B A Keyt, and C K Ferguson, and R G Keck, and R C Chloupek, and R Harris, and W F Bennett, and S E Builder, and W S Hancock
November 1987, Journal of the American College of Cardiology,
G A Vehar, and M W Spellman, and B A Keyt, and C K Ferguson, and R G Keck, and R C Chloupek, and R Harris, and W F Bennett, and S E Builder, and W S Hancock
March 1984, Circulation,
G A Vehar, and M W Spellman, and B A Keyt, and C K Ferguson, and R G Keck, and R C Chloupek, and R Harris, and W F Bennett, and S E Builder, and W S Hancock
March 1991, Bollettino chimico farmaceutico,
G A Vehar, and M W Spellman, and B A Keyt, and C K Ferguson, and R G Keck, and R C Chloupek, and R Harris, and W F Bennett, and S E Builder, and W S Hancock
August 1985, Thrombosis and haemostasis,
G A Vehar, and M W Spellman, and B A Keyt, and C K Ferguson, and R G Keck, and R C Chloupek, and R Harris, and W F Bennett, and S E Builder, and W S Hancock
January 1985, Circulation,
G A Vehar, and M W Spellman, and B A Keyt, and C K Ferguson, and R G Keck, and R C Chloupek, and R Harris, and W F Bennett, and S E Builder, and W S Hancock
January 1991, Biotechnology (Reading, Mass.),
G A Vehar, and M W Spellman, and B A Keyt, and C K Ferguson, and R G Keck, and R C Chloupek, and R Harris, and W F Bennett, and S E Builder, and W S Hancock
October 1984, Circulation,
G A Vehar, and M W Spellman, and B A Keyt, and C K Ferguson, and R G Keck, and R C Chloupek, and R Harris, and W F Bennett, and S E Builder, and W S Hancock
June 1993, Biochimica et biophysica acta,
G A Vehar, and M W Spellman, and B A Keyt, and C K Ferguson, and R G Keck, and R C Chloupek, and R Harris, and W F Bennett, and S E Builder, and W S Hancock
April 1999, Science (New York, N.Y.),
G A Vehar, and M W Spellman, and B A Keyt, and C K Ferguson, and R G Keck, and R C Chloupek, and R Harris, and W F Bennett, and S E Builder, and W S Hancock
November 1991, DICP : the annals of pharmacotherapy,
Copied contents to your clipboard!